The US Food and Drug Administration (FDA) has granted clearance to icotec for the use of its BlackArmor implants in treating de novo spinal infections. This is claimed to make icotec the first and ...
ALTSTÄTTEN, Switzerland and BOSTON, Nov. 13, 2025 /PRNewswire/ -- icotec, the pioneer of implantable devices made from BlackArmor® Engineered Carbon/PEEK, today announced that the U.S. Food and Drug ...
Since receiving FDA clearance in 2019, many designated US cancer centers have adopted icotec's BlackArmor® products. This investment will enable icotec to continue its impressive growth and strengthen ...
ALTSTAETTEN, Switzerland, June 18, 2020 /PRNewswire/ -- icotec ag announces that the KONG®-TL and the KONG®-C vertebral body replacement systems with the unique Titaniumcoating (Ti-iT®) receive FDA ...
DAVOS, Switzerland, March 3, 2020 /PRNewswire/ -- The AO Foundation and icotec ag announce the successful agreement and kick-off for the joint development of a new spinal stabilization system based on ...
ALTSTAETTEN, Switzerland and EAST HARTFORD, Conn., Jan. 24, 2024 /PRNewswire/ -- icotec ag, the leading company in the field of innovative spinal tumor implants is pleased to announce a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results